Post-MGUS Diagnosis Serum Monoclonal-Protein Velocity and the Progression of Monoclonal Gammopathy of Undetermined Significance to Multiple Myeloma.

Su-Hsin ChangJason GumbelSuhong LuoTheodore S ThomasKristen M SanfilippoJingqin LuoDebbie L BennettKenneth R Carson

Published in: Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology (2019)

Our results suggest a new clinical predictor of progression to multiple myeloma following MGUS diagnosis, which has potential to identify high-risk patients for management and prevention.

Keyphrases

multiple myeloma
end stage renal disease
newly diagnosed
chronic kidney disease
ejection fraction
prognostic factors
patient reported outcomes
risk assessment
climate change
blood flow
amino acid
protein protein
human health